STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Ainos, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ainos, Inc. (AIMD) reported a Form 4 showing that Taiwan Carbon Nano Technology Corporation, a director-related reporting person, sold 2,000 shares of common stock on 10/02/2025 at a price of $3.585 per share. After the sale the reporting person beneficially owned 1,044,206 shares. The filing states the shares were sold for general operating purposes. The Form 4 was signed on 10/06/2025 by the reporting entity's chairman and CEO.

Positive

  • Transparent disclosure of the sale via a filed Form 4
  • Large continuing ownership after the sale: 1,044,206 shares remain beneficially owned

Negative

  • Sale described only as for general operating purposes, providing no detailed use of proceeds

Insights

Small insider sale; ownership remains sizable.

The sale of 2,000 shares at $3.585 is a modest disposition relative to the post-transaction beneficial holding of 1,044,206 shares, so it does not materially change control or economic exposure.

This transaction was disclosed as for general operating purposes, which is a non-specific use of proceeds; investors may note the timing on 10/02/2025

Transaction size unlikely to move market; watch insider activity trend.

A sale of 2,000 shares at $3.585 is small and unlikely to affect share liquidity or price by itself. The remaining >1M-share holding means the reporting person still has substantial alignment with equity performance.

Investors who monitor insider behavior should track additional Form 4s for any pattern of sales or open-market dispositions during the coming weeks.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Taiwan Carbon Nano Technology Corp

(Last) (First) (Middle)
10F-2, NO. 66, SHENGYI 5TH RD.,

(Street)
ZHUBEI CITY F5 302

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ainos, Inc. [ AIMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 S 2,000(1) D $3.585 1,044,206 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person sold shares of common stock for general operating purposes.
Taiwan Carbon Nano Technology Corporation By: /s/ Chun-Hsien Tsai, Chairman, Chief Executive Officer 10/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for Ainos (AIMD) report?

It reported that Taiwan Carbon Nano Technology Corporation sold 2,000 shares on 10/02/2025 at $3.585 per share and retained 1,044,206 shares.

Who filed the Form 4 for AIMD?

The filing lists Taiwan Carbon Nano Technology Corporation as the reporting person and is signed by its chairman and CEO on 10/06/2025.

What was the stated reason for the AIMD insider sale?

The filing states the shares were sold for general operating purposes.

Does this sale change control of Ainos (AIMD)?

No. After the sale the reporting person still beneficially owned 1,044,206 shares, so the small 2,000-share sale did not materially change ownership.

When was the transaction executed and reported?

The transaction date is 10/02/2025 and the Form 4 was signed on 10/06/2025.
Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Latest SEC Filings

AIMD Stock Data

9.00M
1.94M
56.73%
0.13%
2.59%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO